Senior Clinical Outcomes Assessment Scientist jobs in United States
cer-icon
Apply on Employer Site
company-logo

Sanofi · 2 months ago

Senior Clinical Outcomes Assessment Scientist

Sanofi is a global healthcare company focused on transforming the practice of medicine. They are seeking a Senior Clinical Outcomes Assessment Scientist to lead the definition of COA endpoint strategies and ensure alignment of COA activities with external standards and internal priorities.

Health CareLife SciencePharmaceuticalTherapeutics
check
H1B Sponsor Likelynote

Responsibilities

The COA Lead is accountable for the definition of COA endpoint strategies and responsible for the conduct of related activities in relation to specific programs, assets, or indications
In addition to serving as COA Lead on a portfolio of programs, the Senior COA Lead provides expertise and strategic input in COA team and beyond
He/she also ensures alignment of COA strategies and activities to 1) external standards (e.g. PFDD); 2) internal organization and priorities; 3) trends in environment and competition
The Senior COA Lead actively participates in the regulatory and commercial dynamic specific to TA, defines and communicates the TA strategic framework, including Core Outcomes Sets and Digital endpoint strategy, provides guidance and support to the COA scientists
The Senior COA Lead is accountable for scientific quality of activities and deliverable in their defined scope
This includes coaching less experienced COA scientists, acting as referral level whenever needed, leading and delivering internal educational programs, reviewing documents, representing the COA team in Sanofi asset and indication strategy meeting, as well as in FDA meetings on invitation
The Senior COA Lead also takes direct accountability of some assets with support of COA scientist
Expertise: The Senior COA Lead delivers senior expertise across the team in one or several methodologies (e.g. Psychometrics, Preference studies, Qualitative Research, Regulatory perspective, and Endpoint definition, etc.)
Innovation: The Senior COA Lead takes accountability of some strategic transversal projects, with support from COA Lead
Exposure: The Senior COA Lead takes responsibilities and represent the COA team in cross-functional initiatives (e.g. with CSO, EDO, DBM). The Senior COA Lead represents Sanofi in consortia and pre-competitive initiatives (e.g. C-Path)

Qualification

Clinical Outcome AssessmentsPsychometricsRegulatory knowledgeDrug development processCOA endpoint strategyInnovationChange managementNetworkingAccountabilityAutonomy

Required

Relevant experience in COA in Pharma/CRO/Consultancy: ideally proven track record from scientific publications in core COA disciplines such COA data analyses and/or creation or validation of new COAs and/or COA endpoint strategy implementation
Knowledge of the drug development process and the regulatory (FDA, EMA, local agencies) and payer (EUnetHTA, NICE, HAS, G-BA, other local agencies) environment
Accountability and hands-on mindset, autonomy, and sense of initiative
Appetite for innovation and change management
Ability to interact and manage external and internal networks
Relevant advanced academic degree (e.g. doctorate or master's degree in psychology, anthropology, sociology, public health, epidemiology, psychometrics, clinical research, physiotherapy, pharmacy, medicine, biostatistics, etc.)

Company

Sanofi is a global biopharma company focused on prescription drugs, vaccines, and treatments for chronic, rare, and infectious diseases.

H1B Sponsorship

Sanofi has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (101)
2024 (68)
2023 (59)
2022 (78)
2021 (38)
2020 (38)

Funding

Current Stage
Public Company
Total Funding
$6.97B
Key Investors
Blackstone Life SciencesEvotec
2025-10-28Post Ipo Debt· $3B
2025-06-17Post Ipo Debt· $1.74B
2025-03-05Post Ipo Debt· $1.59B

Leadership Team

leader-logo
Paul Hudson
Chief Executive Officer
linkedin
leader-logo
Francois-Xavier Roger
Chief Financial Officer
linkedin
Company data provided by crunchbase